Main > > >MSI-H SOLID TUMORS. *

---

TREAT.: PembrolizuMAb Inj.>
(Metastatic/Recurrent)
>progressed after chemotherapy (only if
refractory or intolerant to standard
therapies)
MSI-H: Micro-Satellite Instability-High
JP Approval Date: 2019. 01.03.
(*) Company; Patents; TradeMark & Web-
Site Available on Request.
UpDate: 2019. 01.04.


>MSI-H SOLID TUMORS. *'s products
This section has no products